Emanuele Nicastri

Istituto Nazionale per le Malattie Infettive Lazzaro Spallanzani

Also affiliated with Istituti di Ricovero e Cura a Carattere Scientifico

MedicineImmunology and Microbiology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

1in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Papers

Driven by 15 papers. Top paper: “Emulation of a Target Trial From Observational Data to Compare Effectiveness of Casirivimab/Imdevimab and Bamlanivimab/Etesevimab for Early Treatment of Non-Hospitalized Patients With COVID-19”.

Emulation of a Target Trial From Observational Data to Compare Effectiveness of Casirivimab/Imdevimab and Bamlanivimab/Etesevimab for Early Treatment of Non-Hospitalized Patients With COVID-19

Frontiers in Immunology(2022)10.3389/fimmu.2022.868020

N/A

0.330DataRank · unranked

8 citations

Alessandro Cozzi-Lepri, Francesca Colavita, Simone Lanini, Silvia Rosati, Eleonora Lalle +16 more

Expansion of myeloid-derived suppressor cells in patients with severe coronavirus disease (COVID-19)

Cell Death and Differentiation(2020)10.1038/s41418-020-0572-6

N/A

0DataRank · unranked

245 citations

Alessandra Sacchi, Veronica Bordoni, Eleonora Cimini, Stefania Notari, Germana Grassi +21 more

Early expansion of myeloid-derived suppressor cells inhibits SARS-CoV-2 specific T-cell response and may predict fatal COVID-19 outcome

Cell Death and Disease(2020)10.1038/s41419-020-03125-1

N/A

0DataRank · unranked

117 citations

Germana Grassi, Veronica Bordoni, Patrizia Lorenzini, Eleonora Cimini, Rita Casetti +16 more

COVID-19 disease—Temporal analyses of complete blood count parameters over course of illness, and relationship to patient demographics and management outcomes in survivors and non-survivors: A longitudinal descriptive cohort study

PLoS ONE(2020)10.1371/journal.pone.0244129

N/A

0DataRank · unranked

66 citations

Chiara Montaldo, Emanuele Nicastri, Francesco Vairo, Chiara Agrati, Nicola Petrosillo +19 more

Chikungunya Outbreak in the Republic of the Congo, 2019—Epidemiological, Virological and Entomological Findings of a South-North Multidisciplinary Taskforce Investigation

Viruses(2020)10.3390/v12091020

N/A

0DataRank · unranked

29 citations

Martin Aimè Coussoud-Mavoungou, Francine Ntoumi, Concetta Castilletti, Lambert Kitembo, Najmul Haider +31 more

561. Safety of Remdesivir vs Standard Care in Patients with Moderate Covid-19

Open Forum Infectious Diseases(2020)10.1093/ofid/ofaa439.755

N/A

0DataRank · unranked

5 citations

Mi Young Ahn, Gregory Huhn, Aruna Subramanian, Carlos Lumbreras, Stefan Schmiedel +15 more

Extremely potent human monoclonal antibodies from COVID-19 convalescent patients

Cell(2021)10.1016/j.cell.2021.02.035

N/A

0DataRank · unranked

240 citations

Emanuele Nicastri, Ida Paciello, Piero Pileri, Noemi Manganaro, Giulia Piccini +30 more

2019-novel Coronavirus severe adult respiratory distress syndrome in two cases in Italy: An uncommon radiological presentation

International Journal of Infectious Diseases(2020)10.1016/j.ijid.2020.02.043

N/A

0DataRank · unranked

196 citations

Elisa Pianura, Federica Di Stefano, Massimo Cristofaro, Ada Petrone, Luisa Marchioni +82 more

In-vitro evaluation of the immunomodulatory effects of Baricitinib: Implication for COVID-19 therapy

Journal of Infection(2021)10.1016/j.jinf.2021.02.023

N/A

0DataRank · unranked

57 citations

Elisa Petruccioli, Tonino Alonzi, Valentina Vanini, Gilda Cuzzi, Saeid Najafi Fard +13 more

The unbalanced p53/SIRT1 axis may impact lymphocyte homeostasis in COVID-19 patients

International Journal of Infectious Diseases(2021)10.1016/j.ijid.2021.02.019

N/A

0DataRank · unranked

50 citations

Eleonora Tartaglia, Alessandra Sacchi, Gian María Fimia, Eleonora Cimini, Rita Casetti +13 more

GRAd-COV2, a gorilla adenovirus-based candidate vaccine against COVID-19, is safe and immunogenic in younger and older adults

Science Translational Medicine(2021)10.1126/scitranslmed.abj1996

N/A

0DataRank · unranked

32 citations

Stefania Capone, Andrea Antinori, Stefano Milleri, Emanuele Nicastri, Roberto Camerini +31 more

Humoral and cellular responses to spike of δ SARS-CoV-2 variant in vaccinated patients with immune-mediated inflammatory diseases

International Journal of Infectious Diseases(2022)10.1016/j.ijid.2022.04.027

N/A

0DataRank · unranked

32 citations

Andrea Picchianti-Diamanti, Gian Domenico Sebastiani, Alessandra Aiello, Bruno Laganà, Gilda Cuzzi +11 more

Humoral and Cellular Response to Spike of Delta SARS-CoV-2 Variant in Vaccinated Patients With Multiple Sclerosis

Frontiers in Neurology(2022)10.3389/fneur.2022.881988

N/A

0DataRank · unranked

27 citations

Carla Tortorella, Alessandra Aiello, Chiara Farroni, Serena Ruggieri, Concetta Castilletti +13 more

Small-RNA sequencing identifies serum microRNAs associated with abnormal electrocardiography findings in patients with Chagas disease

Journal of Infection(2025)10.1016/j.jinf.2025.106613

N/A

0DataRank · unranked

3 citations

Alice Blandino, Dominique Scherer, Inés Zulantay, Werner Apt, Nelson Varela +13 more

Coinfection of tuberculosis and COVID-19 limits the ability to in vitro respond to SARS-CoV-2

International Journal of Infectious Diseases(2021)10.1016/j.ijid.2021.02.090

N/A

0DataRank · unranked

104 citations

Elisa Petruccioli, Valentina Vanini, Gilda Cuzzi, Gina Gualano, Pietro Vittozzi +9 more